| 1. Evaluative value of ultrasound contrast for carotid atherosclerotic plaque angiogenesis |
Page:497—499 |
| 2. Exploration of the pathogenesis of hypertension caused by obstructive sleep apnea hypopnea syndrome |
Page:478—482 |
| 3. Plasma level and activity of endotoxin in patients with ischemic stroke |
Page:475—477 |
| 4. Research progress of high intensity interval aerobic training for patients with chronic heart failure |
Page:578—580 |
| 5. New progress of risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy |
Page:574—577 |
| 6. Influence of PDCA nursing on mental state and quality of life in patients with myocardial infarction |
Page:563—566 |
| 7. Role of patient-centered psychological nursing for improving sleep quality of CHD patients |
Page:558—563 |
| 8. Influence of prehospital emergency care connected green channel on rescue effect in patients with acute myocardial infarction |
Page:551—554 |
| 9. Study of high-quality nursing in patients with acute myocardial infarction after percutaneous coronary intervention |
Page:547—550 |
| 10. Influence of secondary turntable abdomen insulin injection positioning ruler on blood glucose and com-plications in patients with diabetes mellitus |
Page:538—541 |
| 11. Influence of benazepril combined trimetazidine on blood FSTL1,PAF and vascular endothelial function in CHD + HF patients |
Page:533—538 |
| 12. Influence of furosemide combined Xinmailong injection on LVEF and blood lactate in patients with chronic heart failure |
Page:529—533 |
| 13. Influence of telmisartan combined amiodarone on blood pressure,left atrial and AF recurrence in pa-tients with hypertension complicated AF |
Page:526—529 |
| 14. Influence of intracoronary tirofiban application on coronary blood flow,endothelial function and in-flammatory factors in AMI patients |
Page:522—526 |
| 15. Anti-platelet/anti-coagulation and their prognosis in advanced aged patients with ACS complicated atri-al fibrillation after PCI |
Page:515—518 |
| 16. High-quality of emergency clinical pathway and therapeutic effect evaluation for PCI in AMI patients |
Page:511—515 |
| 17. Changes of blood adiponectin and heme oxygenase 1 levels after PCI |
Page:507—511 |
| 18. Influence of hydrochlorothiazide combined valsartan on therapeutic effects,cardiac function and levels of serum RBP4,Vaspin in hypertension patients |
Page:503—507 |
| 19. Clinical characteristics of congenital coronary artery fistulas and its coronary angiographic results anal-ysis |
Page:500—502 |
| 20. Role of CYP2C19 gene polymorphism in guidance of anti-platelet therapy after PCI |
Page:493—496 |
| 21. Influence of tanshinone injection combined diltiazem on vascular endothelial function in patients with hypertension |
Page:490—492 |
| 22. Analysis of risk factors for high risk ventricular arrhythmias after emergency PCI |
Page:486—489 |
| 23. Improving effect of cognitive restructuring intervention on mental state and therapeutic compliance in CHD patients |
Page:482—485 |
| 24. Correlation among serum levels of 25 (OH)D,HbA1c,Hcy and intracranial arterial stenosis severity in patients with diabetes mellitus |
Page:470—474 |
| 25. Analysis of risk factors and the prognostic risk factors in aged patients with coronary heart disease |
Page:467—470 |
| 26. Relationship among serum A-FABP,chemokine CXCL12 and onset,severity of AIS in aged AIS pa-tients |
Page:463—466 |
| 27. Progress in the treatment of pulmonary embolism |
Page:570—574 |
| 28. Research progress for pathological mechanism and typing of coronary microcirculation dysfunction |
Page:567—570 |
| 29. Diagnostic value of exercise ECG and dynamic ECG for organic heart disease ventricular premature beat |
Page:542—546 |
| 30. Influence of preoperative intensive atorvastatin therapy on no-reflow and cardiac function after selective PCI |
Page:518—521 |
| 31. Evaluative value of ultrasound contrast for carotid atherosclerotic plaque angiogenesis |
Page:497—499 |
| 32. Exploration of the pathogenesis of hypertension caused by obstructive sleep apnea hypopnea syndrome |
Page:478—482 |
| 33. Plasma level and activity of endotoxin in patients with ischemic stroke |
Page:475—477 |
| 34. Research progress of high intensity interval aerobic training for patients with chronic heart failure |
Page:578—580 |
| 35. New progress of risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy |
Page:574—577 |
| 36. Influence of PDCA nursing on mental state and quality of life in patients with myocardial infarction |
Page:563—566 |
| 37. Role of patient-centered psychological nursing for improving sleep quality of CHD patients |
Page:558—563 |
| 38. Influence of prehospital emergency care connected green channel on rescue effect in patients with acute myocardial infarction |
Page:551—554 |
| 39. Study of high-quality nursing in patients with acute myocardial infarction after percutaneous coronary intervention |
Page:547—550 |
| 40. Influence of secondary turntable abdomen insulin injection positioning ruler on blood glucose and com-plications in patients with diabetes mellitus |
Page:538—541 |
| 41. Influence of benazepril combined trimetazidine on blood FSTL1,PAF and vascular endothelial function in CHD + HF patients |
Page:533—538 |
| 42. Influence of furosemide combined Xinmailong injection on LVEF and blood lactate in patients with chronic heart failure |
Page:529—533 |
| 43. Influence of telmisartan combined amiodarone on blood pressure,left atrial and AF recurrence in pa-tients with hypertension complicated AF |
Page:526—529 |
| 44. Influence of intracoronary tirofiban application on coronary blood flow,endothelial function and in-flammatory factors in AMI patients |
Page:522—526 |
| 45. Anti-platelet/anti-coagulation and their prognosis in advanced aged patients with ACS complicated atri-al fibrillation after PCI |
Page:515—518 |
| 46. High-quality of emergency clinical pathway and therapeutic effect evaluation for PCI in AMI patients |
Page:511—515 |
| 47. Changes of blood adiponectin and heme oxygenase 1 levels after PCI |
Page:507—511 |
| 48. Influence of hydrochlorothiazide combined valsartan on therapeutic effects,cardiac function and levels of serum RBP4,Vaspin in hypertension patients |
Page:503—507 |
| 49. Clinical characteristics of congenital coronary artery fistulas and its coronary angiographic results anal-ysis |
Page:500—502 |
| 50. Role of CYP2C19 gene polymorphism in guidance of anti-platelet therapy after PCI |
Page:493—496 |
| 51. Influence of tanshinone injection combined diltiazem on vascular endothelial function in patients with hypertension |
Page:490—492 |
| 52. Analysis of risk factors for high risk ventricular arrhythmias after emergency PCI |
Page:486—489 |
| 53. Improving effect of cognitive restructuring intervention on mental state and therapeutic compliance in CHD patients |
Page:482—485 |
| 54. Correlation among serum levels of 25 (OH)D,HbA1c,Hcy and intracranial arterial stenosis severity in patients with diabetes mellitus |
Page:470—474 |
| 55. Analysis of risk factors and the prognostic risk factors in aged patients with coronary heart disease |
Page:467—470 |
| 56. Relationship among serum A-FABP,chemokine CXCL12 and onset,severity of AIS in aged AIS pa-tients |
Page:463—466 |
| 57. Progress in the treatment of pulmonary embolism |
Page:570—574 |
| 58. Research progress for pathological mechanism and typing of coronary microcirculation dysfunction |
Page:567—570 |
| 59. Diagnostic value of exercise ECG and dynamic ECG for organic heart disease ventricular premature beat |
Page:542—546 |
| 60. Influence of preoperative intensive atorvastatin therapy on no-reflow and cardiac function after selective PCI |
Page:518—521 |
